Market Currents
GSK (GSK) intends to step up its campaign of attack on Human Genome (HGSI) with a plan to try to...
-
Wednesday, May 30, 2012, 10:45 AM ETGSK (GSK) intends to step up its campaign of attack on Human Genome (HGSI) with a plan to try to replace the biotech's entire board with its own nominees, Reuters reports. GSK will also extend its $2.6B tender offer for Human Genome beyond June 7.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
